The FDA approved labeling changes for elivaldogene autotemcel (eli-cel; Skysona), a one-time gene therapy for patients with early, active cerebral adrenoleukodystrophy (CALD), to reflect new safety ...

While documenting hundreds of abuse cases across Trump’s ICE, BOP, and military facilities, Ossoff’s investigation functions as damage control for a Democratic Party complicit in building and funding ...

Ruth Szymankiewiczat died after she was left alone at Huntercombe Hospital despite requiring constant one-to-one observation, ...

The company's revenue (GAAP) reached $21.2 million, up from $15.3 million in Q2 2024, outpacing the analyst consensus of $20.45 million (GAAP). Earnings per share (EPS, GAAP) were $(0.38), also better ...

Q2 2025 Earnings Call Transcript August 6, 2025 Mirum Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is ...

Uncertainty can be distressing. If you're a manager or leader, here's how you can help your people navigate it.

Q2 2025 Earnings Call Transcript August 6, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.83836, ...

Oral NLRP3 inhibitor BGE-102 on track for Phase 1 initiation in 2H 2025 with initial data by year-end Expanded APJ agonist pipeline through option agreement for novel antibody and advancement of ...

University of New Mexico researchers are joining a multi-site clinical trial of RE104, an experimental psychedelic drug intended to alleviate the mental suffering many patients experience when they ...

Swedish biotech Cellcolabs stem cell therapies are approaching commercial scale — a landmark poised to transform medicine.

Discontinuation rates in pediatric trials remain high, reflecting logistical and clinical obstacles. To overcome these hurdles, clinical research organizations can assist - re-thinking pediatric trial ...

SHELTON, CT / ACCESS Newswire / July 30, 2025 / NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the ...